We are aware of our social and economic impact and the long-term impact of the social environment on our operations.
By continuously investing in research and development, we provide patients worldwide with access to affordable, high-quality, safe and effective innovative generic medicines, which is a cornerstone of our social responsibility.
We treat all stakeholders responsibly, fostering good relations and encouraging a policy driven by equal opportunity and sexual/religious/racial diversity. We maintain a healthy and attractive work environment with fair compensation and respect for human rights.
We are aware that we are part of the broader social environment; in exchange for a so-called “social licence to operate” we make sure we deliver a positive impact the development of the social community we operate in.
During the materiality assessment process, we identified three key areas: Product quality and patient safety, Talent attraction and retention, and Accessible healthcare.